George Cardoza, Chief Financial Officer of SOPHiA GENETICS SA, filed a Form 4 on November 9, 2026, disclosing an open-market purchase of 20,000 ordinary shares on November 6, 2026.

Key Highlights

  • Reporting person: George Cardoza, identified in the filing as Chief Financial Officer of SOPHiA GENETICS SA
  • Transaction: Purchase (transaction code P) of 20,000 ordinary shares on November 6, 2026
  • Weighted average price: $7.06 per share, with individual transactions ranging from $6.74 to $7.12, inclusive
  • Resulting ownership: 326,726 ordinary shares held directly following the transaction
  • Signing authority: Filed by Elimara Brunetto as Attorney-in-Fact for George Cardoza on November 9, 2026

CFO George Cardoza Purchases Ordinary Shares of SOPHiA GENETICS SA

According to the Form 4 filed with the SEC on November 9, 2026, George Cardoza, the Chief Financial Officer of SOPHiA GENETICS SA (NASDAQ:SOPH), acquired 20,000 ordinary shares of the company on November 6, 2026. The filing records the transaction under code "P," indicating an open-market purchase.

The filing reports a weighted average purchase price of $7.06 per share. Per footnote 1 of the filing, the shares were acquired across multiple transactions at prices ranging from $6.74 to $7.12, inclusive. The filing notes that Cardoza "undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."

Following the reported transaction, Cardoza's direct beneficial ownership of ordinary shares stands at 326,726 shares, according to the filing. No derivative securities transactions were reported in Table II. The form was signed by Elimara Brunetto as Attorney-in-Fact for George Cardoza and filed on November 9, 2026.

What Was Disclosed

SOPHiA GENETICS SA's CFO George Cardoza reported the purchase of 20,000 ordinary shares on November 6, 2026 at a weighted average price of $7.06, bringing his directly held shares to 326,726, as disclosed in a Form 4 filed November 9, 2026.